EVALUATE THE ROLE OF HOMOEOPATHIC MEDICINE IN CASES OF GOUT

An Interventional Study to Evaluate The role of Individualized Homoeopathic Medcine In Cases of Gout - NILL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096619

Enrollment

Registered

2025-10-29

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

Intervention1: Homoeopathy: Individualized Homoeopathic Drugs Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: The patient between the age 18 to 45yr. The patient diagnosed with high Uric acid level and nephrolithiasis secondary to hyperuracaemia. The patient giving consent and willing to participate in the study and maintaining follow up

Exclusion criteria

Exclusion criteria: Patient with other severe systemic illness of gout. patient on other analgesic medicine or Co morbidity.

Design outcomes

Primary

Measure	Time frame
1.Reduce pain and redness 2.comparative effectiveness to identify statistical significance between two groups Timepoint: 1.Reduce pain and redness within 8 weeks 2.comparative effectiveness to identify statistical significance between two groups after 8 weeks	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactOM PRAKASH

Sri Ganganagar Homoeopathic Medical College Hospital and Research institute

aggarwal.anil1@gmail.com9929319610

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026